BioSmart Co.,Ltd. Statistics

Total Valuation

BioSmart Co.,Ltd. has a market cap or net worth of KRW 77.97 billion. The enterprise value is 156.87 billion.

Market Cap	77.97B
Enterprise Value	156.87B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

BioSmart Co.,Ltd. has 25.27 million shares outstanding. The number of shares has increased by 22.61% in one year.

Current Share Class	n/a
Shares Outstanding	25.27M
Shares Change (YoY)	+22.61%
Shares Change (QoQ)	+13.38%
Owned by Insiders (%)	24.78%
Owned by Institutions (%)	0.82%
Float	18.75M

Valuation Ratios

The trailing PE ratio is 13.62.

PE Ratio	13.62
Forward PE	n/a
PS Ratio	0.14
PB Ratio	0.60
P/TBV Ratio	0.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.84, with an EV/FCF ratio of -11.16.

EV / Earnings	22.01
EV / Sales	0.33
EV / EBITDA	7.84
EV / EBIT	13.23
EV / FCF	-11.16

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.52.

Current Ratio	1.50
Quick Ratio	0.28
Debt / Equity	0.52
Debt / EBITDA	4.16
Debt / FCF	-5.43
Interest Coverage	1.92

Financial Efficiency

Return on equity (ROE) is 5.19% and return on invested capital (ROIC) is 2.94%.

Return on Equity (ROE)	5.19%
Return on Assets (ROA)	2.41%
Return on Capital (ROIC)	2.94%
Revenue Per Employee	2.98B
Profits Per Employee	44.55M
Employee Count	160
Asset Turnover	1.80
Inventory Turnover	7.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.86%
50-Day Moving Average	3,372.10
200-Day Moving Average	4,092.80
Relative Strength Index (RSI)	45.24
Average Volume (20 Days)	115,163

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSmart Co.,Ltd. had revenue of KRW 477.34 billion and earned 7.13 billion in profits. Earnings per share was 226.57.

Revenue	477.34B
Gross Profit	72.10B
Operating Income	10.19B
Pretax Income	13.61B
Net Income	7.13B
EBITDA	18.33B
EBIT	10.19B
Earnings Per Share (EPS)	226.57

Full Income Statement

Balance Sheet

The company has 26.00 billion in cash and 76.31 billion in debt, giving a net cash position of -50.31 billion or -1,990.48 per share.

Cash & Cash Equivalents	26.00B
Total Debt	76.31B
Net Cash	-50.31B
Net Cash Per Share	-1,990.48
Equity (Book Value)	146.45B
Book Value Per Share	5,114.60
Working Capital	46.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.21 billion and capital expenditures -5.85 billion, giving a free cash flow of -14.06 billion.

Operating Cash Flow	-8.21B
Capital Expenditures	-5.85B
Free Cash Flow	-14.06B
FCF Per Share	-556.25

Full Cash Flow Statement

Margins

Gross margin is 15.10%, with operating and profit margins of 2.13% and 1.49%.

Gross Margin	15.10%
Operating Margin	2.13%
Pretax Margin	2.85%
Profit Margin	1.49%
EBITDA Margin	3.84%
EBIT Margin	2.13%
FCF Margin	n/a

Dividends & Yields

BioSmart Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.61%
Shareholder Yield	-22.61%
Earnings Yield	7.34%
FCF Yield	-18.03%

Stock Splits

The last stock split was on September 20, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Sep 20, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

BioSmart Co.,Ltd. has an Altman Z-Score of 2.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.8
Piotroski F-Score	n/a